Zaleplon, CAS 151319-34-5 Free sample
Zaleplon, CAS 151319-34-5, EE 99.9%, Zaleplon, CAS 151319-34-5,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
Zaleplon, CAS 151319-34-5 stable novel crystalline or amorphous form both we have, Zaleplon, CAS 151319-34-5no any IP problem. Zaleplon, CAS 151319-34-5 DMF filling, free sample of Zaleplon, CAS 151319-34-5.
EOS Med Chem have already carried out Zaleplon, CAS 151319-34-5 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Zaleplon, CAS 151319-34-5 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Zaleplon, CAS 151319-34-5 Intermeidates list, most from GMP plant:
Zaleplon, CAS 151319-34-5 Intermediate 7463-31-2, stock 1.7kg, assay 98.7%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 96605-61-7, stock 8.6kg, assay 98.9%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 96605-66-2, stock 2.2kg, assay 98.8%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 16617-46-2, stock 6.1kg, assay 98.5%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 621-38-5, stock 8.6kg, assay 98.7%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 1080480-69-8, stock 3.2kg, assay 98.1%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 1224288-99-6, stock 4kg, assay 98.6%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 1159982-97-4, stock 3.9kg, assay 98%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 1001-26-9, stock 1.6kg, assay 98.6%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 1384247-59-9, stock 9.8kg, assay 98.3%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 99-03-6, stock 8.7kg, assay 98.7%, White powder.
Zaleplon, CAS 151319-34-5 Intermediate 200630-96-2, stock 2.4kg, assay 99%, White powder.
Zaleplon, CAS 151319-34-5 HNMR, MASS, COA, MSDS we have.
Zaleplon, CAS 151319-34-5, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
